Morten Haugen/LinkedIn
Sep 19, 2025, 16:48
Morten Haugen Warns of IgG Risks for High-Frequency Plasma Donors
Morten Haugen, Resident physician specializing in immunology and transfusion medicine at Oslo University Hospital, shared a post on LinkedIn:
“New evidence on plasma donation frequency:
- The first paper from my PhD-work is now published in Vox Sanguinis! In this randomized trial we found that
High-frequency (3×/2 weeks) and regular-frequency (1×/2 weeks) plasma donation significantly lowered total serum protein and immunoglobulin G. - Up to 26% of high-frequency donors dropped below the IgG safety threshold of 6.0 g/L, even when starting with normal levels of more than 8.0 g/L in most donors.
- Many plasma proteins had not recovered 4 weeks after the last donation.
These findings highlight the need for careful donor monitoring and further research into long-term health effects.
Full article here

Thanks to the volunteer blood donors, the research team and my co-authors Karin Magnussen, Tor Strand and Lise Sofie Nissen-Meyer for making the study possible.”
Stay updated with Hemostasis Today.
-
Oct 24, 2026, 14:28Satyam Arora: Umbilical Cord Blood for Neonatal Transfusions
-
Oct 24, 2026, 13:24Amelia Carro Hevia: Ischaemic Stroke Risk in Atrial Flutter vs Atrial Fibrillation
-
Oct 24, 2026, 12:27Emeka Patrick Chukwuka: Ferritin Falls First – Iron Deficiency Before Anaemia
-
Oct 24, 2026, 11:57Priyanka Kandalgaokar: Sharing India’s Patient Advocacy Journey at MPN Horizon 2026
-
Oct 24, 2026, 11:40Uli Schotten: Coagulation Factors May Influence Cardiac Remodelling
-
Oct 24, 2026, 11:20Edward Lee Carter: Anticoagulation After Intracranial Hemorrhage – Encouraging Data, but an Unresolved Tradeoff
-
Oct 24, 2026, 11:16Aram Hovhannisyan: New Evidence on CAT from the THEO Study
-
Oct 24, 2026, 10:49Shahram Kordasti: Investigating Novel Immune Targets in MPN
-
Oct 24, 2026, 10:32Amber Yates: A Major Milestone for the RISE UP Phase 3 Study